Group 1 - Tianmu Pharmaceutical (600671) experienced a trading halt today with a daily turnover rate of 9.90% and a transaction amount of 178 million yuan, showing a fluctuation of 10.42% [2] - The stock was listed on the Shanghai Stock Exchange due to a daily price deviation of 10.40%, with a net buying amount of 37.9935 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction amount of 97.5753 million yuan, with a buying amount of 67.7844 million yuan and a selling amount of 29.7909 million yuan, resulting in a net buying of 37.9935 million yuan [2] Group 2 - The leading buying brokerage was Kaiyuan Securities Co., Ltd. with a purchase amount of 27.7977 million yuan, while the largest selling brokerage was Guotai Junan Securities Co., Ltd. with a selling amount of 7.1853 million yuan [2] - The stock saw a net inflow of 25.128 million yuan from main funds today, with a significant single net inflow of 37.3034 million yuan and a large single fund outflow of 12.1754 million yuan [2] - Over the past five days, the net inflow of main funds amounted to 14.84 million yuan [2] Group 3 - On April 28, the company released its Q1 report, showing a total revenue of 52.2935 million yuan, representing a year-on-year growth of 88.55%, and a net profit of 5.0943 million yuan, reflecting a year-on-year increase of 152.40% [2] - On July 15, the company announced its half-year performance forecast, expecting a net profit between 8.5 million yuan and 10.5 million yuan [3]
天目药业龙虎榜数据(8月1日)